Britt Jørgensen Email
Safety Surveillance Pharmacovigilance Director @ Novo Nordisk
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Britt Jørgensen Location
- Denmark
Britt Jørgensen Work
- Safety Surveillance Pharmacovigilance Director @ (August 2024 - Present)
- Senior Director, Safety Surveillance Obesity and Metabolism @ (April 2021 - August 2024)
- Manager, Safety Surveillance Phase I and Stem Cells @ (December 2020 - March 2021)
- Safety Surveillance Principal Specialist @ (March 2017 - December 2020)
- Senior Director, Head of Corporate Drug Safety @ (March 2016 - February 2017)
- MD, Head of Safety Surveillance @ (December 2014 - February 2016)
- Principal Medical Safety Advisor @ (September 2014 - November 2014)
- MD, Teamleader, Safety Surveillance Diabetes, Non-insulin Submission Team @ (October 2012 - September 2014)
- MD, Safety Surveillance Specialist @ (July 2010 - September 2012)
- Pharmaceutical Medicine Programme @ (July 2008 - June 2010)
- MD @ Frederiksund sygehus (March 2008 - May 2008)
- MD @ Lægerne Gl. Ølstykke (September 2007 - February 2008)
- MD @ Roskilde sygehus (September 2006 - August 2007)
- MD @ Lægerne Lynge bytorv (March 2006 - August 2006)
- MD @ Hillerød Hospital (September 2005 - February 2006)
- MD @ Hillerød Hospital (March 2005 - August 2005)
Britt Jørgensen Education
- Københavns Universitet - University of Copenhagen
Cand. Med.
1997-2005
Britt Jørgensen Summary
- Britt Jørgensen, based in Denmark, is currently a Safety Surveillance Pharmacovigilance Director at Novo Nordisk. Britt Jørgensen brings experience from previous roles at Novo Nordisk and Genmab. Britt Jørgensen holds a 1997 - 2005 Cand. Med. @ Københavns Universitet - University of Copenhagen. Britt Jørgensen has 1 emails on RocketReach.
Looking for a different Britt Jørgensen?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co